Letter in response to article in journal of infection: "Cardiovascular complications in COVID-19: A systematic review and meta-analysis"

J Infect. 2021 Jan;82(1):159-198. doi: 10.1016/j.jinf.2020.06.074. Epub 2020 Jun 30.

Authors

Dimitrios Giannis¹, Ioannis A Ziogas²

Affiliations

¹ Institute of Health Innovations and Outcomes Research, Feinstein Institute for Medical Research, Manhasset, NY, 11030, United States; Surgery Working Group, Society of Junior Doctors, Athens, Greece. Electronic address: [email protected].
² Department of Surgery, Vanderbilt University Medical Center, Nashville, TN, 37232 United States; Surgery Working Group, Society of Junior Doctors, Athens, Greece. Electronic address: [email protected].

No abstract available

Keywords: Coagulation; Coronavirus; Covid-19; Thromboprophylaxis; Thrombosis; Venous thromboembolism.

Publication types

Letter
Comment

MeSH terms

Anticoagulants
COVID-19*
Humans
SARS-CoV-2

Substances

Anticoagulants